Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (ABVX) Profit After Tax: 2022-2025

Historic Profit After Tax for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to -$114.1 million.

  • Abivax's Profit After Tax fell 173.24% to -$114.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$210.9 million, marking a year-over-year increase of 14.70%. This contributed to the annual value of -$188.3 million for FY2024, which is 18.48% down from last year.
  • Abivax's Profit After Tax amounted to -$114.1 million in Q2 2025, which was down 107.10% from -$55.1 million recorded in Q1 2025.
  • Abivax's Profit After Tax's 5-year high stood at -$61.93 during Q4 2022, with a 5-year trough of -$159.0 million in Q4 2023.
  • Its 3-year average for Profit After Tax is -$69.4 million, with a median of -$50.8 million in 2024.
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 256,679,870.16% in 2023, then skyrocketed by 100.00% in 2024.
  • Over the past 4 years, Abivax's Profit After Tax (Quarterly) stood at -$61.93 in 2022, then crashed by 256,679,870.16% to -$159.0 million in 2023, then spiked by 100.00% to -$188.29 in 2024, then slumped by 173.24% to -$114.1 million in 2025.
  • Its Profit After Tax was -$114.1 million in Q2 2025, compared to -$55.1 million in Q1 2025 and -$188.29 in Q4 2024.